Table 2.
Patients’ clinical characteristics
| Characteristics | COVID-19 (n = 88) | Non-COVID-19 (n = 80) | Overall (n = 168) | p value |
|---|---|---|---|---|
| Clinical characteristics | ||||
| Age | 47.3 ± 12.4 | 42.8 ± 17.3 | 45.2 ± 15.1 | 0.053 |
| Male | 42, 47.7% | 30, 37.5% | 72, 42.9% | 0.182 |
| History of exposure | 68, 77.3% | 20, 25% | 88, 52.4% | < 0.001 |
| Laboratory tests | ||||
| Leukocyte count (×109 per L) (range, 3.5–9.5) | 4.6 (3.5, 5.7) | 6.8 (4.5, 9.1) | 5.4 (3.9, 7.2) | < 0.001 |
| Decrease | 23 | 6 | 29 | |
| Increase | 1 | 17 | 18 | |
| Neutrophil count (× 109 per L) (range, 1.8–6.3) | 2.9 (2.0, 3.9) | 4.4 (2.7, 7.0) | 3.3 (2.3, 5.2) | < 0.001 |
| Decrease | 17 | 7 | 24 | |
| Increase | 3 | 23 | 26 | |
| Lymphocyte count (× 109 per L) (range 1.1–3.2) | 1.2 (1.0, 1.6) | 1.3 (1.0, 1.9) | 1.3 (1.0, 1.7) | 0.115 |
| Decrease | 28 | 26 | 54 | |
| Increase | 2 | 2 | 4 | |
| Platelet count (× 109 per L) (range 125–350) | 179.5 (141.0, 223.5) | 217.5 (174.5, 274.8) | 202 (152.3, 250.3) | < 0.001 |
| Decrease | 5 | 10 | 15 | |
| Increase | 5 | 4 | 9 | |
| C-reactive protein (mg/L, 0.0–6.0) | 8.6 (3.1, 23.4) | 12.1 (3.1, 33.6) | 10.1 (3.1, 25.5) | 0.363 |
| Increase | 32 | 56 | 88 | |
COVID-19 coronavirus disease 2019